BPC-157 + TB-500 is a two-component research blend. The supplied 10 mg report labels 5 mg of each peptide and explicitly describes TB-500 as Ac-LKKTETQ. The separate 20 mg report names the components without printing that fragment definition.
Compare the two supplied blend reports
The supplied reports label equal masses of BPC-157 and TB-500, with different totals. Each also gives component-specific measured content, so the label and assay can be read without treating them as the same field.Supplied BPC-157 + TB-500 10 mg report — lot BPT-42-7LP (opens in a new tab)Supplied BPC-157 + TB-500 20 mg report — lot BLD-08-2B3 (opens in a new tab)
| Report | Labelled BPC-157 / TB-500 | Measured BPC-157 / TB-500 |
|---|---|---|
| 10 mg total, BPT-42-7LP | 5 mg / 5 mg | 5.02 mg / 4.98 mg |
| 20 mg total, BLD-08-2B3 | 10 mg / 10 mg | 10.00 mg / 10.01 mg |
Sequence detail is report-specific
BPC-157 has the sequence GEPPPGKPADDAGLV in its chemical reference. The 10 mg blend report defines its TB-500 component as Ac-LKKTETQ; retain the acetyl prefix with that seven-residue sequence. These are two component identities, rather than one combined peptide sequence.PubChem — BPC-157, CID 9941957 (opens in a new tab)Supplied BPC-157 + TB-500 10 mg report — lot BPT-42-7LP (opens in a new tab)
The 20 mg blend report and the standalone TB-500 report do not print the complete TB-500 sequence. The explicit Ac-LKKTETQ wording in the 10 mg blend document cannot fill those other reports’ structural gaps. Request the qualified-reference specification for the particular report when that comparison is needed.Supplied BPC-157 + TB-500 10 mg report — lot BPT-42-7LP (opens in a new tab)Supplied BPC-157 + TB-500 20 mg report — lot BLD-08-2B3 (opens in a new tab)Supplied TB-500 5 mg report — lot TB5-06-SQQ (opens in a new tab)
A single molecular formula, molecular weight or CAS number is not assigned to this mixture. The BPC-157 and TB-500 identity guides preserve the component reference fields and their separate source limitations.Supplied BPC-157 + TB-500 10 mg report — lot BPT-42-7LP (opens in a new tab)Supplied BPC-157 + TB-500 20 mg report — lot BLD-08-2B3 (opens in a new tab)
Read component assays and area purity separately
The 10 mg report states that the combined area percentage represents both target peptides, while content was determined independently. The 20 mg report likewise says that its purity figure describes resolved peptide-related substances, rather than the proportion of one component. Use the component assay rows for the mass comparison.Supplied BPC-157 + TB-500 10 mg report — lot BPT-42-7LP (opens in a new tab)Supplied BPC-157 + TB-500 20 mg report — lot BLD-08-2B3 (opens in a new tab)
Product and certificate documents
Sources and further detail
- Supplied BPC-157 + TB-500 10 mg report — lot BPT-42-7LP (opens in a new tab)
Supplied report: identity wording and analytical fields. Results concern the named sample and lot; this is document transcription, not independent authentication.
- Supplied BPC-157 + TB-500 20 mg report — lot BLD-08-2B3 (opens in a new tab)
Supplied report: identity wording and analytical fields. Results concern the named sample and lot; this is document transcription, not independent authentication.
- Supplied TB-500 5 mg report — lot TB5-06-SQQ (opens in a new tab)
Supplied report: identity wording and analytical fields. Results concern the named sample and lot; this is document transcription, not independent authentication.
- PubChem — BPC-157, CID 9941957 (opens in a new tab)
Existing BPC-157 dossier: sequence identity only in this blend comparison.
Identity sources and supplied documents checked for this revision on 3 October 2026. Report transcription is separate from independent authentication. This article has not undergone independent scientific peer review.